Job title: Head of Emerging Technologies
Szczepan Baran is Head of Emerging Technologies at Novartis
In this position, Dr. Baran leads development & implementation of strategic vision for emerging technologies to optimize non-clinical models of efficacy, mechanism, and safety that improve endpoint prediction, reproducibility and clinical predictivity. He spearheads
– digital biomarker and endpoint strategy and alignment with disease areas and clinical franchises
– internal groups and resources for platforms that offer alternatives to traditional pre-clinical modeling, such as microphysiological systems
– & builds high performance cross-functional teams that accelerate validation and readiness of emerging technologies that foster a culture of collaboration and high performance innovation.
PANEL DISCUSSION: The Future of 3D Tissue Model Adoption 11:00 am
day: Day One